StockDrifts LogoStockDrifts

Rice Hall James & Associates 13F Portfolio

Portfolio Manager
Rice Hall James & Associates LLC
Performance
+8.14% (2026 Q2)
AUM (13F)
$2.05B
# of Holdings
240
Performance Rank
Allocation (Top 20)
37.87%
Latest filing
Q2 2026

Rice Hall James & Associates LLC Holdings Map

Top 50 Rice Hall James & Associates LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
LGND
LIGAND PHARMACEUTICALS INC
4.15%270.1K$85.4M
-4.77%(-13.52K)
2025-Q2: 337.3K shares2025-Q3: 294.5K shares2025-Q4: 279.6K shares2026-Q1: 283.6K shares2026-Q2: 270.1K shares
$77.45(+284.54%)
2026-06-30
ACIW
ACI WORLDWIDE INC
2.46%1.01M$50.6M
+0.32%(+3.24K)
2025-Q2: 900.4K shares2025-Q3: 996.6K shares2025-Q4: 981.3K shares2026-Q1: 1.00M shares2026-Q2: 1.01M shares
$31.33(+68.35%)
2026-06-30
ARLO
ARLO TECHNOLOGIES INC
2.45%3.73M$50.3M
+2.00%(+73.07K)
2025-Q2: 3.85M shares2025-Q3: 3.48M shares2025-Q4: 3.58M shares2026-Q1: 3.66M shares2026-Q2: 3.73M shares
$7.59(+96.17%)
2026-06-30
FN
FABRINET
2.4%87.6K$49.2M
-17.24%(-18.24K)
2025-Q2: 122.2K shares2025-Q3: 111.0K shares2025-Q4: 106.5K shares2026-Q1: 105.8K shares2026-Q2: 87.6K shares
$180.15(+195.40%)
2026-06-30
ESTA
ESTABLISHMENT LABS HLDGS INC
2.34%560.9K$48.1M
+2.23%(+12.26K)
2025-Q2: 837.7K shares2025-Q3: 760.2K shares2025-Q4: 651.6K shares2026-Q1: 548.7K shares2026-Q2: 560.9K shares
$49.61(+50.36%)
2026-06-30
XPO
XPO INC
2.25%224.9K$46.2M
+0.26%(+579)
2025-Q2: 244.0K shares2025-Q3: 223.6K shares2025-Q4: 219.2K shares2026-Q1: 224.3K shares2026-Q2: 224.9K shares
$15.87(+1173.79%)
2026-06-30
ZD
ZIFF DAVIS INC
2.09%821.5K$43.0M
+2.71%(+21.68K)
2025-Q2: 832.1K shares2025-Q3: 753.2K shares2025-Q4: 744.2K shares2026-Q1: 799.8K shares2026-Q2: 821.5K shares
$49.85(+9.84%)
2026-06-30
FOUR
SHIFT4 PMTS INC
2.07%874.5K$42.5M
+3.16%(+26.77K)
2025-Q2: 341.1K shares2025-Q3: 584.2K shares2025-Q4: 663.8K shares2026-Q1: 847.7K shares2026-Q2: 874.5K shares
$79.76(-46.39%)
2026-06-30
KNSA
KINIKSA PHARMACEUTICALS INTL
1.95%624.9K$40.0M
+2.71%(+16.51K)
2025-Q2: 638.2K shares2025-Q3: 577.8K shares2025-Q4: 596.4K shares2026-Q1: 608.4K shares2026-Q2: 624.9K shares
$19.68(+288.98%)
2026-06-30
LRN
STRIDE INC
1.84%439.0K$37.9M
+0.12%(+541)
2025-Q2: 333.0K shares2025-Q3: 305.4K shares2025-Q4: 427.8K shares2026-Q1: 438.4K shares2026-Q2: 439.0K shares
$48.54(+65.83%)
2026-06-30

About Rice Hall James & Associates LLCโ€™s portfolio

Rice Hall James & Associates LLC reports $2.05B in US-listed equity holdings across 240 positions in its most recent 13F filing. Its largest disclosed positions are LGND (4.2%), ACIW (2.5%) and ARLO (2.5%). The top 20 holdings account for 37.87% of reported assets. Its disclosed equity book has returned +49.72% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
LGND โ€” 6.4% ($85.36M)ACIW โ€” 3.8% ($50.62M)ARLO โ€” 3.8% ($50.32M)FN โ€” 3.7% ($49.23M)ESTA โ€” 3.6% ($48.13M)XPO โ€” 3.5% ($46.17M)ZD โ€” 3.2% ($43.02M)FOUR โ€” 3.2% ($42.54M)KNSA โ€” 3.0% ($39.96M)LRN โ€” 2.9% ($37.86M)Other โ€” 62.8% ($833.62M)
37%in top 10
  • LGND6.4%
  • ACIW3.8%
  • ARLO3.8%
  • FN3.7%
  • ESTA3.6%
  • XPO3.5%
  • ZD3.2%
  • FOUR3.2%
  • KNSA3.0%
  • LRN2.9%
  • Other62.8%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
1
OSKOSHKOSH CORP0.8%
Added to
39
UPWKUPWORK INC+112.3%
BMRNBIOMARIN PHARMACEUTICAL INC+137.2%
PBHPRESTIGE CONSMR HEALTHCARE I+32.2%
VRDNVIRIDIAN THERAPEUTICS INC+30.9%
+35 more
Trimmed
10
FNFABRINET-17.2%
YOUCLEAR SECURE INC-16.0%
LGNDLIGAND PHARMACEUTICALS INC-4.8%
MIRMMIRUM PHARMACEUTICALS INC-24.7%
+6 more

Unlock alerts, watchlists & AI chat

Sign up free to track Rice Hall James & Associates LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Rice Hall James & Associates LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1230765). View Rice Hall James & Associates LLCโ€™s 13F filings on SEC

More 13F analyses

View all